Recurrent chronic thromboembolic disease despite optimal anticoagulation in setting of recent COVID-19 infection.
infectious diseases, Pulmonary Embolism, venous thromboembolism, haematology (drugs and medicines)
We present a case of a 38-year-old man with a history of chronic thromboembolic pulmonary hypertension on therapeutic anticoagulation and recent hospitalisation for COVID-19 disease who was hospitalised for recurrent acute pulmonary embolism despite therapeutic anticoagulation with warfarin (International Normalized Ratio (INR) of 3.0). Our case highlights the hypercoagulable state associated with COVID-19 disease and the absence of standardised approaches to anticoagulation treatment for this population.
Vittorio Romeo Terrigno, Daniel Anthony Ricketti, Pranav Patel, Satyajeet Roy